{
    "clinical_study": {
        "@rank": "63864", 
        "biospec_descr": {
            "textblock": "Whole blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate CD8 + T-cell receptor (TCR) repertoire\n      differences between patients with type 1 diabetes mellitus and type 2 diabetes or healthy\n      controls."
        }, 
        "brief_title": "Sequencing T-cells in Type I Diabetes Mellitus", 
        "completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus, Type 2", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "Using a systems biology approach by combining high-throughput sequencing, cytometry, gene\n      expression, transcriptome profiling, HLA typing, single cell analysis, and TCR affinity\n      assays, the investigators will define a set of immune metrics for the prediction or early\n      diagnosis of disease that is superior to the current examination of auto-antibodies, which\n      is a fairly late stage in the disease development. This can also be used to guide therapy in\n      advanced disease."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients must have a current or previous diagnosis of Type I Diabetes\n             (Autoimmune-related T1DA as confirmed by a positive test for glutamic acid\n             decarboxylase (GAD) auto-antibodies.  When available, idiopathic T1DB patients with a\n             lack of autoantibodies to GAD will be recruited)\n\n          -  Patients must be \u2265 18 years old and \u226445 years old\n\n          -  Male\n\n          -  Caucasian\n\n        Inclusion criteria: patients T2D as controls\n\n          -  Patients must have a current or previous diagnosis of T2D\n\n          -  Patients must be \u2265 18 years old and \u226445 years old\n\n          -  Male\n\n        Exclusion Criteria:\n\n          -  Non-Caucasian\n\n          -  Female\n\n          -  <18 years old; > 45 years old"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Endocrinology clinic patients currently receiving treatment for Type II Diabetes"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02040337", 
            "org_study_id": "CR-14-021"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 25, 2014", 
        "location": {
            "contact": {
                "last_name": "Poppy Poth", 
                "phone": "512-324-1000", 
                "phone_ext": "89612"
            }, 
            "facility": {
                "address": {
                    "city": "Austin", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "78701"
                }, 
                "name": "University of Texas Physicians at Trinity"
            }, 
            "investigator": {
                "last_name": "Mrinalini Kulkarni-Date, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Sequencing T-cell Receptor Repertoire of Auto-Antigen Specific T-cells in Type I Diabetes Mellitus", 
        "overall_contact": {
            "email": "pepoth@seton.org", 
            "last_name": "Poppy Poth", 
            "phone": "512-324-1000", 
            "phone_ext": "89612"
        }, 
        "overall_official": {
            "affiliation": "Seton Family of Hospitals", 
            "last_name": "Mrinalini Kulkarni-Date, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Sensitivity and specificity of T cell repertoire analysis to classify Type I Diabetes", 
            "safety_issue": "No", 
            "time_frame": "3 month intervals for 2 years.  Time to assess effectiveness is 1 year."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02040337"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Seton Family of Hospitals", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Seton Clinical Research Pilot Grant Program", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Cancer Prevention Research Institute of Texas", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Seton Family of Hospitals", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}